药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dezocine
Metreleptin
The metabolism of Cabazitaxel can be increased when combined with Metreleptin.
Dezocine
Danoprevir
The metabolism of Cabazitaxel can be decreased when combined with Danoprevir.
Dezocine
Ribociclib
The metabolism of Cabazitaxel can be decreased when combined with Ribociclib.
Dezocine
Stiripentol
The metabolism of Cabazitaxel can be decreased when combined with Stiripentol.
Dezocine
Elvitegravir
The metabolism of Cabazitaxel can be decreased when combined with Elvitegravir.
Dezocine
Ditiocarb
The metabolism of Cabazitaxel can be decreased when combined with Ditiocarb.
Dezocine
Midostaurin
The metabolism of Cabazitaxel can be decreased when combined with Midostaurin.
Dezocine
Troleandomycin
The metabolism of Cabazitaxel can be decreased when combined with Troleandomycin.
Dezocine
Cobicistat
The metabolism of Cabazitaxel can be decreased when combined with Cobicistat.
Dezocine
Boceprevir
The metabolism of Cabazitaxel can be decreased when combined with Boceprevir.
Dezocine
Armodafinil
The metabolism of Cabazitaxel can be increased when combined with Armodafinil.
Dezocine
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Cabazitaxel.
Dezocine
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Cabazitaxel.
Dezocine
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Cabazitaxel.
Dezocine
Roflumilast
Roflumilast may increase the immunosuppressive activities of Cabazitaxel.
Dezocine
Idelalisib
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Idelalisib.
Dezocine
Siponimod
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Siponimod.
Dezocine
Bleselumab
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Bleselumab.
Dezocine
Rozanolixizumab
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Rozanolixizumab.
Dezocine
Risankizumab
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Risankizumab.